ALVAC-CEA vaccine
From Wikipedia, the free encyclopedia
ALVAC-CEA vaccine is a cancer vaccine containing a canary pox virus (ALVAC) combined with the carcinoembryonic antigen (CEA) human gene.
A phase I trial in 118 patients showed safety in humans.[1]
References[edit]
External links[edit]
- ALVAC-CEA vaccine entry in the public domain NCI Dictionary of Cancer Terms
This article incorporates public domain material from the U.S. National Cancer Institute document "Dictionary of Cancer Terms".
|
|||||||||||||||||||||||||||||||||||||||||
| This oncology article is a stub. You can help Wikipedia by expanding it. |
| This vaccine article is a stub. You can help Wikipedia by expanding it. |